- Home
- COEP vs TPCS Comparison
COEP vs TPCS Comparison
Compare COEP & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- TPCS
- Stock Information
- Founded
- COEP 2017
- TPCS 1956
- Country
- COEP United States
- TPCS United States
- Employees
- COEP N/A
- TPCS N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- TPCS Metal Fabrications
- Sector
- COEP Health Care
- TPCS Industrials
- Exchange
- COEP Nasdaq
- TPCS Nasdaq
- Market Cap
- COEP 32.4M
- TPCS 31.5M
- IPO Year
- COEP N/A
- TPCS N/A
- Fundamental
- Price
- COEP $12.31
- TPCS $3.09
- Analyst Decision
- COEP
- TPCS
- Analyst Count
- COEP 0
- TPCS 0
- Target Price
- COEP N/A
- TPCS N/A
- AVG Volume (30 Days)
- COEP 121.3K
- TPCS 22.0K
- Earning Date
- COEP 03-25-2025
- TPCS 01-21-2025
- Dividend Yield
- COEP N/A
- TPCS N/A
- EPS Growth
- COEP N/A
- TPCS N/A
- EPS
- COEP N/A
- TPCS N/A
- Revenue
- COEP N/A
- TPCS $33,182,059.00
- Revenue This Year
- COEP N/A
- TPCS N/A
- Revenue Next Year
- COEP N/A
- TPCS N/A
- P/E Ratio
- COEP N/A
- TPCS N/A
- Revenue Growth
- COEP N/A
- TPCS 6.44
- 52 Week Low
- COEP $2.31
- TPCS $2.85
- 52 Week High
- COEP $13.70
- TPCS $5.95
- Technical
- Relative Strength Index (RSI)
- COEP 62.60
- TPCS 41.57
- Support Level
- COEP $8.65
- TPCS $3.06
- Resistance Level
- COEP $13.70
- TPCS $3.21
- Average True Range (ATR)
- COEP 1.89
- TPCS 0.13
- MACD
- COEP -0.21
- TPCS 0.01
- Stochastic Oscillator
- COEP 72.48
- TPCS 17.24
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.